These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27482649)

  • 1. Reply.
    Polachek A; Touma Z; Anderson M; Eder L
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):457. PubMed ID: 27482649
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Disease Risk in Psoriatic Arthritis-Common Soil Due to Proinflammatory State and Autoimmune Activation: Comment on the Article by Polachek et al.
    Onat A; Altay S; Karakoyun S
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):456-457. PubMed ID: 27482863
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: Cardiovascular risk in psoriatic arthritis; should we focus on hypertension and diabetes only? Gkaliagkousi et al.
    Favarato MH; Goldenstein-Schainberg C
    Clin Exp Rheumatol; 2014; 32(6):996. PubMed ID: 25233825
    [No Abstract]   [Full Text] [Related]  

  • 4. Dr. Tam,
    Lam SH; Shen J; Tam LS
    J Rheumatol; 2018 Aug; 45(9):1330-1332. PubMed ID: 30173182
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis: comment on 'Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review' by Jamnistki et al.
    González-Gay MA; González-Juanatey C; Llorca J; Castañeda S
    Ann Rheum Dis; 2014 May; 73(5):e27. PubMed ID: 24442882
    [No Abstract]   [Full Text] [Related]  

  • 6. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.
    Yim KM; Armstrong AW
    Rheumatol Int; 2017 Jan; 37(1):97-105. PubMed ID: 27221457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation?
    Kristensen SL; McInnes IB; Sattar N
    Ann Rheum Dis; 2015 Feb; 74(2):321-2. PubMed ID: 25429028
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis.
    Jamnitski A; Visman IM; Peters MJ; Boers M; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2011 May; 70(5):875-6. PubMed ID: 20956406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular risk factors in psoriatic and rheumatoid arthritis].
    Rebrov AP; Nikitina NM; Gaĭdukova IZ
    Ter Arkh; 2011; 83(5):20-4. PubMed ID: 21780652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk in psoriatic arthritis: should we focus on hypertension and diabetes only?
    Gkaliagkousi E; Gavriilaki E; Aslanidis S; Douma S
    Clin Exp Rheumatol; 2014; 32(6):995. PubMed ID: 25236816
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular Morbidity in Psoriatic Arthritis: What Is the Effect of Inflammation?
    Eder L; Harvey P
    J Rheumatol; 2017 Sep; 44(9):1295-1297. PubMed ID: 28864663
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
    Boehncke WH; Gladman DD; Chandran V
    J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to: 'The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis' by Gonzalez-Gay et al.
    Nurmohamed MT; Jamnitski A; Symmons D; Peters MJ; Sattar N; McInnes I
    Ann Rheum Dis; 2014 May; 73(5):e28. PubMed ID: 24577335
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comorbidities in psoriasic arthritis].
    Zürcher S; Boehncke WH; Boehncke S
    Rev Med Suisse; 2014 Apr; 10(424):734-7. PubMed ID: 24772805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
    Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidities in Psoriatic Arthritis.
    Husni ME
    Rheum Dis Clin North Am; 2015 Nov; 41(4):677-98. PubMed ID: 26476226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS).
    Dalal DS; Lin YC; Brennan DM; Borkar N; Korman N; Husni ME
    Semin Arthritis Rheum; 2015 Jun; 44(6):641-5. PubMed ID: 26058346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and causes of death in psoriatic arthritis.
    Arumugam R; McHugh NJ
    J Rheumatol Suppl; 2012 Jul; 89():32-5. PubMed ID: 22751588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in psoriatic arthritis: pathogenesis and management.
    de Vlam K; Gottlieb AB; Mease PJ
    Acta Derm Venereol; 2014 Nov; 94(6):627-34. PubMed ID: 24573106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.